This discovery aligns with a recent investigation that suggested that modified BRCA1 expression in peripheral T cells could lead to aberrant transcription, which is linked to antitumor immunity, and which could potentially contribute to the elevated cancer risk observed in women carrying BRCA1 mutations [34]. Here, BRCA1 is linked to cancer.